{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:17:37Z","timestamp":1789132657381,"version":"build-2803163510"},"reference-count":41,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cardiovasc Pharmacol Ther"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>Hyperkalemia is a potentially life-threatening condition, and patients who have chronic kidney disease, who are diabetic, or who are taking renin\u2013angiotensin\u2013aldosterone system inhibitors are at increased risk. Therapeutic options for hyperkalemia tend to have limited effectiveness and can be associated with serious side effects. Colonic potassium secretion can increase to compensate when urinary potassium excretion decreases in patients with renal impairment, but this adaptation is insufficient and hyperkalemia still results. Patiromer is a novel, spherical, nonabsorbed polymer designed to bind and remove potassium, primarily in the colon, thereby decreasing serum potassium in patients with hyperkalemia. Patiromer has been found to decrease serum potassium in patients with hyperkalemia having chronic kidney disease who were on renin\u2013angiotensin\u2013aldosterone system inhibitors. Results of nonclinical studies and an early phase clinical study are reported here. Two studies with radiolabeled drug, one in rats and the other in dogs, confirmed that patiromer was not absorbed into the systemic circulation. Results of an in vitro study showed that patiromer was able to bind 8.5 to 8.8 mEq of potassium per gram of polymer at a pH similar to that found in the colon and had a much higher potassium-binding capacity compared with other resins, including polystyrene sulfonate. In a study in hyperkalemic rats, a decrease in serum potassium was observed via an increase in fecal potassium excretion. In a clinical study in healthy adult volunteers, a significant increase in fecal potassium excretion and a significant decrease in urinary potassium excretion were observed. Overall, patiromer is a high-capacity potassium binder, and the chemical and physical characteristics of patiromer may lead to good clinical efficacy, tolerability, and patient acceptance.<\/jats:p>","DOI":"10.1177\/1074248416629549","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T20:23:46Z","timestamp":1454963026000},"page":"456-465","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":106,"title":["Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia"],"prefix":"10.1177","volume":"21","author":[{"given":"Lingyun","family":"Li","sequence":"first","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jamie","family":"Cope","sequence":"additional","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Park","sequence":"additional","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Lee","sequence":"additional","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faleh","family":"Salaymeh","sequence":"additional","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidre","family":"Madsen","sequence":"additional","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade W.","family":"Benton","sequence":"additional","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Berman","sequence":"additional","affiliation":[{"name":"Relypsa, Inc, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Buysse","sequence":"additional","affiliation":[{"name":"Tricida, Inc, South San Francisco, CA, USA Guest Editor: Sharon L. Hale"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"932","volume-title":"Medical Physiology: A Cellular and Molecular Approach","author":"Binder HJ.","year":"2005","unstructured":"Binder HJ. Intestinal fluid and electrolyte movement In: Boron WF, Boulpaep EL Medical Physiology: A Cellular and Molecular Approach. Philadelphia, PA: Elsevier Saunders; 2005:932\u2013946."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.160"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90184-8"},{"key":"e_1_3_2_5_2","first-page":"453","volume-title":"The Kidney","author":"Malnic GB","year":"2004","unstructured":"Malnic GB, Baily MA, Giebisch GH. Control of renal potassium excretion. In: Brenner B, Rector FC, editors. The Kidney. 7th ed. London, UK: Saunders; 2004:453\u2013496.","edition":"7"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-009-0781-9"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02233563"},{"issue":"12","key":"e_1_3_2_8_2","first-page":"1007","article-title":"The electrolyte content faeces","volume":"58","author":"Wrong O","year":"1965","unstructured":"Wrong O, Metcalfegibson A. The electrolyte content faeces. Proc R Soc Med. 1965;58(12):1007\u20131009.","journal-title":"Proc R Soc Med"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1977.73"},{"key":"e_1_3_2_10_2","first-page":"207","article-title":"An extravenal mechanism for the maintenance of potassium balance in severe chronic renal failure","volume":"80","author":"Hayes CP","year":"1967","unstructured":"Hayes CPJr, McLeod ME, Robinson RR. An extravenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans Assoc Am Physicians. 1967;80:207\u2013216.","journal-title":"Trans Assoc Am Physicians"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(86)80120-2"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0710393"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0730247"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcp159"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1750"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.132"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067140"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18569"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0944"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.067"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730010-00007"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2005.00638.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02886_8.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196101192640302"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010010079"},{"key":"e_1_3_2_26_2","unstructured":"Kayexalate (sodium polystyrene sulfonate) [Package Insert]. Sanofi-Aventis Inc. Quebec Canada 2014."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00556.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116764.53225.A9"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0906797"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2007.0017"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410853"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.7446"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.270"},{"key":"e_1_3_2_34_2","volume-title":"Dean\u2019s Handbook of Organic Chemistry","author":"Gokel G","year":"2004","unstructured":"Gokel G, Dean J. Dean\u2019s Handbook of Organic Chemistry. 2nd ed. New York, NY: McGraw-Hill; 2004.","edition":"2"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063324"},{"key":"e_1_3_2_36_2","first-page":"282","article-title":"Sodium depletion as a therapeutic procedure: the value of ion-exchange resins in withdrawing sodium from the body","volume":"59","author":"Dock W","year":"1946","unstructured":"Dock W. Sodium depletion as a therapeutic procedure: the value of ion-exchange resins in withdrawing sodium from the body. Tr A Am Physicians. 1946;59(May):282.","journal-title":"Tr A Am Physicians"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.402"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-6411(00)00084-9"},{"issue":"3","key":"e_1_3_2_39_2","first-page":"183","article-title":"Intraluminal pH of the human gastrointestinal tract","volume":"46","author":"Fallingborg J","year":"1999","unstructured":"Fallingborg J. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull. 1999;46(3):183\u2013196.","journal-title":"Dan Med Bull"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(80)90925-7"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.01.017"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-222"}],"container-title":["Journal of Cardiovascular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1074248416629549","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1074248416629549","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1074248416629549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:42:25Z","timestamp":1777394545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1074248416629549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1177\/1074248416629549"],"URL":"https:\/\/doi.org\/10.1177\/1074248416629549","relation":{},"ISSN":["1074-2484","1940-4034"],"issn-type":[{"value":"1074-2484","type":"print"},{"value":"1940-4034","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]}}}